Can AI Detect Heart Problems From Wearables?

What Heart Problems Can a Wearable Actually Detect?

Overwhelmingly, one condition dominates the evidence: atrial fibrillation, or AFib, an irregular heart rhythm that raises stroke risk and often produces no noticeable symptoms. This is by far the most studied, most validated, and most clinically meaningful heart-related use of wearable AI, and it is the reason the Apple Watch became the first smartwatch with FDA clearance for a cardiac feature back in 2018, with the Samsung Galaxy Watch later gaining similar clearance.

Beyond AFib, wearables can flag general high or low heart rate, which is useful but far less specific, and some newer research is exploring hypertension notifications, though those currently perform notably worse. What wearables categorically cannot do, and every manufacturer's own documentation says this explicitly, is detect a heart attack directly.

Why Do Studies Report Such Different Accuracy Numbers for the Same Condition?

The same watch that reliably tracks your workout heart rate cannot reliably rule out a heart attack.

That wide range for the background feature is not a contradiction, it reflects genuinely different study populations. In screening studies of otherwise healthy people, the background feature performs closer to the higher end because true AFib cases are rare and any detection is a meaningful catch. In studies of people who already have diagnosed, intermittent AFib, sensitivity for a single point-in-time background check drops much lower, since the feature only checks periodically and can simply miss a brief episode that happens between checks.

What Did the 2026 EQUAL Trial Actually Find?

The EQUAL trial, a randomized controlled trial of 437 adults aged 65 and older published in the Journal of the American College of Cardiology in January 2026, is one of the strongest pieces of evidence in this entire category because it was a true randomized trial, not just an observational study. Patients wearing a smartwatch were diagnosed with new AFib 9.6% of the time, compared to just 2.3% with standard care, a hazard ratio of 4.40.

The most striking finding: 57% of the smartwatch-detected cases were completely asymptomatic, meaning these were people who felt fine and would very likely have gone undiagnosed without continuous wearable monitoring. That is the strongest possible argument for wearable heart monitoring: catching a genuinely dangerous, silent condition that would otherwise have been missed entirely.

Is Wearable AFib Detection Useful for Everyone, or Mainly Certain People?

The strongest evidence specifically targets older adults, the EQUAL trial enrolled adults 65 and older, a population where AFib prevalence and stroke risk from undetected AFib are both meaningfully higher than in younger populations. For a healthy 25-year-old with no cardiac risk factors, the same feature is far less likely to ever detect anything meaningful, simply because the underlying condition it is built to catch is much rarer at that age.

This does not mean the feature is useless for younger users, but it does mean the practical value of wearable AFib detection scales with your baseline cardiac risk. If you have risk factors, family history, prior heart issues, or simply are getting into the age range where AFib becomes more common, the feature carries genuinely more expected value for you specifically than it does for a low-risk younger user.

Why Can a Smartwatch Not Detect a Heart Attack?

Every study of wearable heart detection recommends confirming any alert with a clinician.

A heart attack, medically a myocardial infarction, is caused by a blocked artery cutting off blood supply to heart muscle, a mechanical and structural problem. It is not reliably associated with the kind of rhythm irregularity a wearable's AFib detection is built to catch, and no current consumer wearable sensor measures the specific biomarkers, like troponin levels in blood, that clinically confirm a heart attack. Apple's own support documentation states this explicitly and directly: the Apple Watch cannot detect heart attacks, and anyone experiencing chest pain, pressure, or tightness should call emergency services immediately regardless of what their watch says or does not say.

This is the single most important safety point in this entire guide. A clean, unremarkable reading from your watch during chest pain or other heart attack warning signs should never be interpreted as reassurance. The absence of a wearable alert does not rule out a medical emergency, and every major manufacturer is explicit about this limitation.

Are These Features Actually Regulated the Same Way as Medical Devices?

Yes, and this is an important distinction from most consumer health app features. The Apple Watch's ECG app and irregular rhythm notification feature went through actual FDA clearance processes, backed by clinical trials with hundreds of participants and defined sensitivity and specificity metrics, the same regulatory bar described throughout our AI diagnosis guide for imaging tools.

That puts wearable heart rhythm detection in a different category from most of what a watch does. Step counting, calorie estimates, and sleep scores are general wellness features with no FDA clearance requirement. AFib detection specifically has cleared that bar, which is exactly why it carries stronger published evidence than nearly any other wearable health metric.

How Should You Respond to a Heart-Related Wearable Alert?

For the deeper mechanics of how the sensors behind these features actually work, see our smartwatch monitoring explainer, and for the full range of what wearable data can and cannot tell you beyond just the heart, our smartwatch data guide covers the broader picture.

The Single Most Important Takeaway

Wearable AFib detection is one of the best-validated, most genuinely useful pieces of consumer health AI that exists today, backed by randomized trial evidence and real FDA clearance. Wearable heart attack detection does not exist, full stop, and no marketing claim from any manufacturer suggests otherwise. Keep both of those facts in mind at the same time, and you will use the technology exactly as intended: as a genuine early-warning tool for one specific condition, not as a general substitute for recognizing and acting on emergency symptoms.

What About Blood Pressure and Wearables?

Blood pressure deserves a specific mention alongside AFib because it is often marketed similarly but performs quite differently. As noted earlier, Apple Watch hypertension notifications miss undiagnosed high blood pressure more than half the time, a much weaker showing than the AFib features on the same device. If managing blood pressure is a priority, a validated home blood pressure cuff remains the more dependable tool, with your wearable serving as a supplementary trend indicator rather than a primary measurement device.

Frequently Asked Questions